Neurobo Pharmaceuticals Inc NRBO:NASDAQ

Last Price$15.80NASDAQ Previous Close - Last Trade as of 3:58PM ET 4/03/20

Today's Change+1.53(10.72%)
Bid (Size)$14.52 (3)
Ask (Size)$15.90 (9)
Day Low / High$14.01 - 16.24
Volume11.9 K
 

View Biotechnology IndustryPeer Comparison as of 04/03/2020

 

Neurobo Pharmaceuticals Inc ( NASDAQ )

Price: $15.80
Change: +1.53 (10.72%)
Volume: 11.9 K
3:58PM ET 4/03/2020
 
 

Gritstone Oncology Inc ( NASDAQ )

Price: $6.10
Change: -0.16 (2.56%)
Volume: 163.5 K
4:00PM ET 4/03/2020
 
 

Sutro Biopharma Inc ( NASDAQ )

Price: $9.40
Change: -0.79 (7.75%)
Volume: 32.3 K
3:59PM ET 4/03/2020
 
 

AMAG Pharmaceuticals Inc ( NASDAQ )

Price: $6.14
Change: +0.06 (0.99%)
Volume: 367.5 K
4:00PM ET 4/03/2020
 
 

Fulcrum Therapeutics Inc ( NASDAQ )

Price: $9.11
Change: -1.32 (12.66%)
Volume: 55.0 K
3:59PM ET 4/03/2020
 

Read more news Recent News

NeuroBo Pharmaceuticals's Net Loss Widens in 2019 as Operating Expenses Grow
6:42AM ET 3/31/2020 MT Newswires

NeuroBo Pharmaceuticals Inc. (NRBO) on Monday reported a net loss of $4.08 per share for the year ended Dec. 31, compared with a loss of $3.65 per share a...

NeuroBo Pharmaceuticals Names Richard Kang President & Chief Executive Officer
2:51PM ET 2/14/2020 MT Newswires

NeuroBo Pharmaceuticals (NRBO) said Richard Kang has been appointed president and chief executive officer retrospectively from Jan. 1. Shares jumped by...

Gemphire Therapeutics Expects to Close Merger With NeuroBo Pharmaceuticals Monday
12:30PM ET 12/30/2019 MT Newswires

Gemphire Therapeutics (GEMP) said that its pending merger with NeuroBo Pharmaceuticals is expected to close after market hours Monday. Gemphire's...

After Hours Watch List Scorecard: GEMP, FEYE, X
5:17PM ET 10/09/2019 MT Newswires

Here's how the stocks on Tuesday's After Hours Watch List performed during today's regular session AFTER HOURS REGULAR SESSION GEMP +4.91% ...

View all Commentary and Analysis

Gemphire And Gemcabene: Closure And The End
8:34AM ET 7/31/2019 Seeking Alpha

Gemphire And Gemcabene: The Orphan First Approach Is An Excellent Clinical Refocus
9:11PM ET 5/27/2019 Seeking Alpha

Company Profile

Business DescriptionNeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders. The company was founded on October 30, 2014 and is headquartered in Boston, MA.
Address200 Berkeley Street
Boston, Massachusetts 02116
Phone+1.617.313.7331
Number of Employees9
Recent SEC Filing04/01/2020S-8
President, Chief Executive & Financial OfficerJeong Gu Kang
Chief Medical OfficerMark Versavel
Vice President-Clinical OperationsNicola Shannon

Company Highlights

Price Open$14.01
Previous Close$14.27
52 Week Range$5.95 - 36.22
Market Capitalization$247.7 M
Shares Outstanding15.7 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement05/14/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.90
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-419.70%

Analyst Ratings as of 02/14/2020

Buy
1
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset